NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00006207

Locations: 🇺🇸
Julia Welch, Research Triangle Park, North Carolina, United States

Effects of Storage on Lactate in Blood Samples

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 13

Registration Number: NCT00011050

Locations: 🇺🇸
UCSF - San Francisco Gen Hosp, San Francisco, California, United States
🇺🇸
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis, Indiana, United States
🇺🇸
Indiana Univ Hosp, Indianapolis, Indiana, United States

A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

Completed

Conditions: Mycobacterium Avium-Intracellulare Infection
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00000907

Locations: 🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
San Mateo AIDS Program / Stanford Univ, Stanford, California, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States

and more 21 locations

A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 75

Registration Number: NCT00000905

Locations: 🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Univ of Cincinnati, Cincinnati, Ohio, United States
🇺🇸
Willow Clinic, Menlo Park, California, United States

and more 22 locations

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Phase 1

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 45

Registration Number: NCT00006153

Locations: 🇺🇸
Joanne Santangelo, San Diego, California, United States

HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

Completed

Conditions: Cognitive Disorders
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT00001103

Locations: 🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸
Ohio State Univ Hosp Clinic, Columbus, Ohio, United States
🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States

and more 23 locations

Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00000818

Locations: 🇺🇸
Univ of Texas Southwestern Med Ctr of Dallas, Dallas, Texas, United States
🇺🇸
Baylor College of Medicine / Houston Veterans Adm Med Ctr, Houston, Texas, United States
🇺🇸
Univ of Illinois, Chicago, Illinois, United States

and more 6 locations

A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-15

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00001007

Locations: 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Hosp - Pediatric, Baltimore, Maryland, United States
🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States

and more 3 locations

Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2010-04-26

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00001097

Locations: 🇺🇸
Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, United States
🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Connecticut Children's Med Ctr, Farmington, Connecticut, United States

and more 43 locations

Observing Patients With Early HIV Infection

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2010-03-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 10

Registration Number: NCT00005020

Locations: 🇺🇸
Joanne Santangelo, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy